Rare Disease Today—December 10, 2025
This week’s rare disease update highlights major regulatory milestones,…
Cardiovascular Today—December 10, 2025
This week’s cardiovascular update brings together new clinical evidence, device…
Lucid Diligence Brief: EpilepsyGTx $33m Series A
Lucid Diligence Brief: EpilepsyGTx $33m Series A Professional audiences only.…
Immunology Today—December 10, 2025
This week’s Immunology update highlights key advances in gene therapy,…
Women’s Health Video Recap—December 10, 2025
This biweekly Women’s Health video roundup brings together new clinical…
Neuroscience Video Recap—December 10, 2025
This biweekly Neuroscience video recap highlights major regulatory wins,…
Neuroscience Today — December 10, 2025
This week’s Neuroscience update features major regulatory decisions, strong…
Lucid Diligence Brief: SanegeneBio RNAi $110 million Series B
Lucid Diligence Brief: SanegeneBio RNAi $110 million Series B Professional…
ESMO Immuno-Oncology 2025 Preview: Key Highlights to Watch
ESMO Immuno-Oncology 2025 at a glance Get ready for ESMO Immuno-Oncology…
Obesity Video Recap—December 9, 2025
This biweekly obesity video recap covers major GLP-1 therapeutic advances,…
Obesity Today—December 9, 2025
This week’s obesity update spotlights key developments, regulatory milestones,…
Endocrinology Today—December 9, 2025
Catch the latest endocrinology news, featuring industry updates, clinical…








